Search
for
Sort by
Research 181–210 of 1000+
- Long-acting microneedle formulations
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Skin manifestations of hyperandrogenism: an update
- Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): a case report
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Diagnosis and Management of Infertility due to Anovulation
- Pharmacology of antiandrogens
- Therapeutic Androgen Receptor Ligands
- Hot Flashes in a Young Girl: A Wake-up Call Concerning Serenoa repens Use in Children
- Updates on Hirsutism: A Narrative Review
- Suety and Spreading-Stromal Hyperplasia and Hyperthecosis Ovary
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Men??s Health
- Polycystic Ovary Syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Chapter 23. Therapeutic Control of Androgen Action
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Hyperadrenocorticism in Ferrets
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol